Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Hansol Kim et al.|Cell stem cell|2021Cited by 153
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environmentsPhilippa R Kennedy, Martin Felices, Upasana Sunil Arvindam et al.|Science Advances|2024Cited by 45
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targetingKristin M. Snyder, Bruce Walcheck, Kate Dixon et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Nicholas A. Zorko et al.|Cancer Immunology Research|2024Cited by 9
755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cellsJeffrey S. Miller, Martin Felices, Nicholas A. Zorko et al.|Annals of Oncology|2022Cited by 9